Determinants of prevalence, awareness, treatment and control of high LDL-C in Turkey

Simple item page
dc.contributor.authorSözmen K.
dc.contributor.authorÜnal B.
dc.contributor.authorSakarya S.
dc.contributor.authorDinç G.
dc.contributor.authorYardım N.
dc.contributor.authorKeskinkılıç B.
dc.contributor.authorErgör G.
dc.date.accessioned2024-07-22T08:12:19Z
dc.date.available2024-07-22T08:12:19Z
dc.date.issued2016
dc.description.abstractObjective: High blood cholesterol is one of the main modifiable risk factors for cardiovascular diseases (CVDs). The aim of the study is to determine the factors associated with the prevalence, awareness, treatment, and control of high "low-density lipoprotein-cholesterol" (LDL-C) among adults aged ≥ 20 years in Turkey. Methods: We used data from Chronic Diseases and Risk Factors Survey conducted in 2011-2012. The presence of high LDL-C, lipid-lowering treatment eligibility, and achievement of target LDL-C were defined according to the third Adult Treatment Panel guidelines on treatment of high cholesterol. Multivariate logistic regression analyses were performed to determine the associations between participant characteristics and high LDL-C prevalence, awareness, treatment, and control. Results: Framingham risk score categorization was performed for 13121 individuals aged ≥ 20 years. Approximately, 28% of the participants presented with high LDL-C. Among those with high LDL-C, 55.8% were aware of their situation; among those aware of high LDL-C, 46.9% were receiving lipidlowering medication, and 50.6% of individuals who were receiving treatment achieved target LDL-C levels on the basis of their coronary heart disease (CHD) risk. Control of high LDL-C was negatively associated with the presence of diabetes mellitus (odds ratio: 0.36, 95% CI: 0.27-0.49, p< 0.001). Conclusion: Despite the high awareness rates, there was a high proportion of adults who did not receive treatment or achieve recommended levels of LDL-C during treatment. The low treatment and control levels among individuals based on their CHD risk levels call for a better application of recommendations regarding personal preventive measures and treatments in Turkey. © 2016 by Turkish Society of Cardiology.
dc.identifier.DOI-ID10.14744/AnatolJCardiol.2016.7018
dc.identifier.issn21492263
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16004
dc.language.isoEnglish
dc.publisherTurkish Society of Cardiology
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectAdult
dc.subjectCholesterol, HDL
dc.subjectCholesterol, LDL
dc.subjectFemale
dc.subjectHumans
dc.subjectHypercholesterolemia
dc.subjectMale
dc.subjectPrevalence
dc.subjectRisk Factors
dc.subjectTurkey
dc.subjectYoung Adult
dc.subjectglucose
dc.subjecthexokinase
dc.subjecthigh density lipoprotein cholesterol
dc.subjectlow density lipoprotein cholesterol
dc.subjecthigh density lipoprotein cholesterol
dc.subjectlow density lipoprotein cholesterol
dc.subjectabdominal obesity
dc.subjectadult
dc.subjectaged
dc.subjectalcohol consumption
dc.subjectArticle
dc.subjectawareness
dc.subjectblood pressure measurement
dc.subjectcerebrovascular accident
dc.subjectcoronary artery bypass graft
dc.subjectdisease control
dc.subjectfemale
dc.subjectFramingham risk score
dc.subjecthuman
dc.subjecthypercholesterolemia
dc.subjecthypertension
dc.subjectischemic heart disease
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectnon insulin dependent diabetes mellitus
dc.subjectphysical activity
dc.subjectsmoking
dc.subjectsystolic blood pressure
dc.subjectTurkey (republic)
dc.subjecthypercholesterolemia
dc.subjectprevalence
dc.subjectrisk factor
dc.subjectturkey (bird)
dc.subjectyoung adult
dc.titleDeterminants of prevalence, awareness, treatment and control of high LDL-C in Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu